ContraFect Announces Second Quarter 2016 Results

YONKERS, NY (Marketwired August 09, 2016) ContraFect Corporation(CFRX) (CFRXW), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for lifethreatening,
drugresistant infectious diseases, today announces results for the second quarter ended June 30, 2016.

This entry was posted in Recent Development News: Q3 - 2016, Recent Developments. Bookmark the permalink.
Read Full Article »